Neuroblastoma Protocol 2012: Therapy for Children With Advanced Stage High-Risk Neuroblastoma
Phase of Trial: Phase II
Latest Information Update: 26 Dec 2017
At a glance
- Drugs Dinutuximab (Primary) ; Antineoplastics; Natural killer cell therapy
- Indications Neuroblastoma
- Focus Therapeutic Use
- 19 Dec 2017 Planned End Date changed from 31 Jul 2021 to 1 Jul 2021.
- 19 Dec 2017 Planned primary completion date changed from 31 Jan 2021 to 1 Jan 2021.
- 05 Jun 2017 Results assessing early response rates (n=42), presented at the 53rd Annual Meeting of the American Society of Clinical Oncology